Nobel Biocare showcased the role digital technology plays in implant diagnostics, treatment planning and guided surgery at its Symposium in New York City in June.
That’s the question on everyone’s mind these days, especially since the NADL released an alert on the in-house milling of custom abutments in November. Here are the details, including the NADL’s alert, the FDA’s heightened enforcement efforts, and responses from the marketplace.